scispace - formally typeset
L

Luca Ronfani

Researcher at University of Trieste

Publications -  248
Citations -  118143

Luca Ronfani is an academic researcher from University of Trieste. The author has contributed to research in topics: Population & Mortality rate. The author has an hindex of 67, co-authored 221 publications receiving 83759 citations. Previous affiliations of Luca Ronfani include IRCCS Materno Infantile Burlo Garofolo & James Cook University.

Papers
More filters
Journal ArticleDOI

Impact of maternal body mass index and gestational weight gain on pregnancy complications: An individual participant data meta-analysis of European, North American and Australian cohorts

Susana Santos, +87 more
TL;DR: In this paper, the separate and combined associations of maternal pre-pregnancy body mass index (BMI) and gestational weight gain with the risks of pregnancy complications and their population impact were assessed.
Journal ArticleDOI

Maternal body mass index, gestational weight gain and the risk of overweight and obesity across childhood: An individual participant data meta-analysis

Ellis Voerman, +91 more
- 11 Feb 2019 - 
TL;DR: In this article, the authors conducted an individual participant data meta-analysis of data from 162,129 mothers and children from 37 pregnancy and birth cohort studies from Europe, North-America and Australia, using multilevel binary logistic regression models with a random intercept at cohort level adjusted for maternal socio-demographic and life style related characteristics.
Journal ArticleDOI

Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.

TL;DR: IgA-EmA and IgA-anti-TG2/EmA tests appear highly accurate to diagnose coeliac disease in children and may help in excluding CD, while POC tests show inferior accuracy.
Journal ArticleDOI

Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

Joseph R. Zunt, +185 more
- 01 Dec 2018 - 
TL;DR: Meningitis burden remains high and progress lags substantially behind that of other vaccine-preventable diseases, and particular attention should be given to developing vaccines with broader coverage against the causes of meningitis.